417 results match your criteria: "Birmingham Heersink School of Medicine[Affiliation]"
JAMA Pediatr
November 2024
Division of Child & Adolescent Psychiatry, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Importance: Anxiety, depression, and attention-deficit/hyperactivity disorder (ADHD) affect up to 20% of children and adolescents. Despite demonstrated efficacy, evidence-based treatments for these conditions are often inaccessible; innovative solutions are essential to meet the demand for pediatric mental health care.
Objective: To examine the efficacy and moderators of gamified DMHIs for anxiety, depression, and ADHD in randomized clinical trials (RCTs) for children and adolescents.
Curr Opin Pediatr
December 2024
Department of Genetics, University of Alabama at Birmingham Heersink School of Medicine.
Purpose Of Review: A growing number of gene therapies are getting FDA-approved for pediatric rare disorders to treat once incurable diseases. Opportunities for preventing lifetime illness and improving quality of life for these patients is now becoming a reality. Challenges exist in navigating the complexities of determining which patients will benefit from these new gene therapies and how to effectively deliver them as a standard of care.
View Article and Find Full Text PDFJ Surg Res
November 2024
Division of Surgical Oncology, Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland. Electronic address:
Introduction: Advanced retroperitoneal sarcoma (RPS) can include unresectable locoregional disease, systemic or multifocal intra-abdominal metastasis, or abdominal sarcomatosis, all of which are associated with high morbidity and may be addressed through palliative therapy. Current trends in the use of palliative therapy and factors associated with its use in patients with advanced RPS remain largely unexplored. The objectives of this study are to (1) describe the temporal trend in the use of palliative therapy and (2) identify factors associated with its use in patients with advanced RPS in the United States from 2004 to 2020.
View Article and Find Full Text PDFAcad Emerg Med
September 2024
Cardiac Arrest Registry to Enhance Survival (CARES) Surveillance Group, Atlanta, Georgia, USA.
Semin Thromb Hemost
September 2024
Department of Health Informatics, Data Coordinating Center for Pediatric Multicenter Studies, Johns Hopkins All Children's Institute for Clinical and Translational Research, St. Petersburg, Florida.
Trauma Surg Acute Care Open
September 2024
Trauma and Acute Care Surgery, The University of Alabama at Birmingham Heersink School of Medicine, Birmingham, Alabama, USA.
Blood Adv
November 2024
Department of Medicine, Division of Oncology, Stanford Cancer Institute, Stanford University Medical Center, Stanford University, Stanford, CA.
Circulation
September 2024
Sports Cardiology Program, Knight Cardiovascular Institute, Oregon Health and Science University, Portland (B.J.P.).
Gastrointest Endosc Clin N Am
October 2024
Gastrointestinal Endoscopy Division, Instituto D´Or de Pesquisa e Ensino (IDOR), Hospital Vila Nova Star, R. Dr. Alceu de Campos Rodrigues, 126 - Vila Nova Conceição, São Paulo, São Paulo 04544-000, Brazil; Gastrointestinal Endoscopy Unit, Department of Gastroenterology, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Av. Dr. Enéas de Carvalho Aguiar, 255 Cerqueira César, 05403-000, Brazil.
Innovations (Phila)
December 2024
Department of Cardiothoracic Surgery, University of Alabama Birmingham, AL, USA.
Objective: Reoperative surgery for isolated tricuspid valve (TV) pathology has been associated with high morbidity and mortality rates; however, the current guidelines recommend intervention for severe, symptomatic TV regurgitation or mild to moderate symptoms with progressive right ventricular dysfunction. There are minimal data regarding reoperative intervention for TV disease. Similarly, there are no large series describing robot-assisted reoperative TV surgery.
View Article and Find Full Text PDFJMIR Med Educ
September 2024
Harvard Medical School, Boston, US.
Background: Recent studies, including those by the National Board of Medical Examiners (NBME), have highlighted the remarkable capabilities of recent large language models (LLMs) such as ChatGPT in passing the United States Medical Licensing Examination (USMLE). However, there is a gap in detailed analysis of these models' performance in specific medical content areas, thus limiting an assessment of their potential utility for medical education.
Objective: To assess and compare the accuracy of successive ChatGPT versions (GPT-3.
J Diabetes
September 2024
Department of Pediatrics, University of Alabama at Birmingham Heersink School of Medicine, Birmingham, Alabama, USA.
ACG Case Rep J
September 2024
Division of Gastroenterology & Hepatology, Department of Internal Medicine, Basil I. Hirschowitz Endoscopic Center of Excellence, The University of Alabama at Birmingham Heersink School of Medicine, Birmingham, AL.
Am J Perinatol
October 2024
Division of Reproductive Genetics, Department of Obstetrics and Gynecology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.
Am J Med Genet A
January 2025
The Mindich Child Health and Development Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Cancer Med
September 2024
Department of Pathology, University of Alabama at Birmingham Heersink School of Medicine, Birmingham, Alabama, USA.
Objective: The TGF-β superfamily member activin, a dimer of the gene products of INHBA and/or INHBB, has been implicated in immune cell maturation and recruitment, but its immune impact within epithelial ovarian cancer (EOC) is not well characterized. We sought to explore differences in activin (INHBA/ Inhibin-βA and INHBB/ Inhibin-βB) between malignant and ovarian tissues at the RNA and protein level and assess the relationship between activin and immune cells in EOC.
Methods: Publicly available RNA sequencing data were accessed from GEO (#GSE143897) with normalization and quantification performed via DESeq2.
Obstet Gynecol
November 2024
University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina; University of Alabama at Birmingham Heersink School of Medicine, Birmingham, Alabama; UTHealth Houston McGovern Medical School, Baylor College of Medicine, and Texas Children's Hospital, Houston, and University of Texas Medical Branch Galveston, Galveston, Texas; Columbia University Irving Medical Center, New York, New York; University of South Carolina School of Medicine Greenville/Prisma Health-Upstate, Greenville, South Carolina; University of California, San Diego, San Diego, California; University of Pennsylvania Perelman School of Medicine and Temple University Lewis Katz School of Medicine, Philadelphia, Pennsylvania; The Ohio State University College of Medicine and Wexner Medical Center, Columbus, Ohio; University of Mississippi Medical Center, Jackson, Mississippi; Indiana University School of Medicine Indianapolis, Indiana; Rutgers Health/Robert Wood Johnson Medical School, New Brunswick, New Jersey; Oregon Health & Science University Portland, Oregon; and Ochsner Health New Orleans, Louisiana.
Objective: To estimate the association between maternal metformin use for the treatment of early gestational or pre-existing type 2 diabetes and preterm preeclampsia.
Methods: This is a planned secondary analysis of the MOMPOD study (Medical Optimization of Management of Overt Type 2 Diabetes in Pregnancy), a randomized trial comparing the effect of adding metformin with insulin treatment on composite neonatal outcome in singleton pregnancies with early gestational or type 2 diabetes. Participants were randomized at 11-23 weeks of gestation to 1,000 mg metformin twice daily or placebo until delivery.
AJR Am J Roentgenol
November 2024
Department of Radiology, St. Jude Children's Research Hospital, 262 Danny Thomas Pl, Memphis, TN 38105-3678.
Retrospective studies evaluating artificial intelligence (AI) algorithms for intracranial hemorrhage (ICH) detection on noncontrast CT (NCCT) have shown promising results but lack prospective validation. The purpose of this article was to evaluate the impact on radiologists' real-world aggregate performance for ICH detection and report turnaround times for ICH-positive examinations of a radiology department's implementation of an AI triage and notification system for ICH detection on head NCCT examinations. This prospective single-center study included adult patients who underwent head NCCT examinations from May 12, 2021, to June 30, 2021 (phase 1), or from September 30, 2021, to December 4, 2021 (phase 2).
View Article and Find Full Text PDFJ Addict Med
November 2024
From the Division of General Internal Medicine, Department of Medicine, University of Utah School of Medicine, Salt Lake City, UT (MAI); Program for Addiction Research, Clinical Care, Knowledge, and Advocacy (PARCKA); Division of Epidemiology, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT (MAI, SH, KS, AJG); Division of Epidemiology, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT (SH, KS, AJG); University of Oregon, Eugene, OR (SG); and Birmingham Alabama Veterans Affairs Health Care System and University of Alabama at Birmingham Heersink School of Medicine, Birmingham, AL (SGK).
Objectives: Hospitals are increasingly offering treatment for substance use disorders (SUDs) during medical admissions. However, there is a lack of consensus on the best approach to facilitating a successful transition to long-term medical and SUD care after hospitalization. We aimed to establish a hierarchy of existing SUD care transition models in 2 categories-effectiveness and implementation-using an expert consensus approach.
View Article and Find Full Text PDFObjectives: This study aimed to characterize the clinical outcomes, safety, and efficacy of lumen-apposing metal stents (LAMS) in treating benign gastrointestinal strictures.
Methods: A single-center retrospective review of all patients who underwent LAMS placement for benign strictures from June 2017 to July 2023. Primary outcomes were technical success, early clinical success, late clinical success (LCS), and sustained post-LAMS clinical success (SPLCS).
Drug Alcohol Depend Rep
September 2024
Department of Emergency Medicine, University of Alabama at Birmingham, Birmingham, AL, United States.
Background: An increase in opioid-related overdoses, notably from potent synthetic opioids like fentanyl, prompted this consideration of characteristics of emergency department (ED) patients with evidence for illicit fentanyl use or exposure, the correlation with intentional opioid misuse, and subsequent ED management.
Methods: A retrospective review was performed of patients presenting to an urban academic medical center ED with evidence for illicit fentanyl use, determined by positive urine drug screens (UDS), from 6/2021 through 11/2021. Participant demographics, comorbidities, ED chief complaint and disposition, and evidence of intentional opioid misuse were considered.
Sex Transm Infect
August 2024
Diagnostic Solutions, Becton, Dickinson and Company, Sparks, Glencoe, Maryland, USA.
Background: The decision to use a particular test to diagnose patients presenting with symptoms of vaginitis and/or STI is based primarily on the prevailing standards of care in the clinic at which the patient evaluation takes place. As a result, laboratory testing of vaginal samples for these patients often involves either an STI or a vaginitis test, but rarely both options simultaneously, which complicates the diagnosis and management of concurrent infections.
Methods: Using de-identified remnant vaginal specimens from symptomatic patients previously tested for STI ( (CT), (GC) and (TV)) with the Becton Dickinson (BD) CTGCTV2 assay for BD MAX System, positivity for bacterial vaginosis (BV) and spp (associated with vulvovaginal candidiasis (VVC)) were evaluated using the molecular-based BD MAX Vaginal Panel.
Cell Death Dis
August 2024
Division of Hematology/Oncology, Department of Medicine, University of Alabama at Birmingham Heersink School of Medicine, Birmingham, AL, USA.
BCL-2 inhibitors such as venetoclax offer therapeutic promise in acute myeloid leukemia (AML) and other cancers, but drug resistance poses a significant challenge. It is crucial to understand the mechanisms that regulate venetoclax response. While correlative studies have identified numerous genes linked to venetoclax sensitivity, their direct impact on the drug response remains unclear.
View Article and Find Full Text PDFAdv Radiat Oncol
September 2024
Division of Nuclear Medicine and Molecular Imaging, Department of Radiology and Imaging Sciences, Emory University, Atlanta, Georgia.
Gastro Hep Adv
April 2024
Department of Pathology, University of Alabama at Birmingham Heersink School of Medicine, Birmingham, Alabama.